Long-lasting adenovirus transgene expression in mice through neonatal lntrathymic tolerance induction without the use of immunosuppression

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5330-5335

  DeMatteo, R P ^a   Chu, G ^a   Ahn, M ^a   Chang, E ^a   Barker, C F ^a   Markmann, J F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENE; VIRUS INFECTION; VIRUS RECOMBINATION;

EID: 0030908652     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5330-5335.1997     Document Type: Article

References (25)

1. Adzick, N. S., and M. R. Harrison. 1994. Fetal surgical therapy. Lancet 343:897-902.
2. Cihak, J., and F. Lehmann-Grube. 1978. Immunological tolerance to lymphocytic chorio-meningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism. Immunology 34:265-275.
3. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles 10 success. Science 270:404-410.
4. Dai, Y., E. M. Schwarz, D. Gu, W. Zhang, N. Sarvetnick, and I. M. Verma. N95. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
5. DeMatteo, R. P., J. F. Markmann, K. F. Kozarsky, C. F. Barker, and S. E. Raper. 1996. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther. 3:4-12.
6. DeMatteo, R. P., S. E. Raper, M. Ahn, K. J. Fisher, C. Burke, A. Radu, G. Widera, B. R. Claytor, C. F. Barker, and J. F. Markmann. 1995. Gene transfer to the thymus: a means to abrogate the immune response to recombinant adenovirus. Ann. Surg. 222:229-242.
7. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6196-6200.
8. H2 immunity in neonatal mice. Science 271:1728-1730.
9. Haj-Ahmed, Y., and F. L. Graham. 1986. Development of a helper independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J. Virol. 57:267-274.
10. Ilan, Y., P. Attavar, M. Takahashi, A. Davidson, M. S. Horwitz, J. Guida, N. R. Chowdhury, and J. R. Chowdhury. 1996. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats. J. Clin. Invest. 98:2640-2647.
11. Kass-Eisler, A., E. Falck-Pederson, D. H. Elfenbein, M. Alvira, P. M. Buttrick, and L. A. Leinwand. 1994. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:395-402.
12. Kay, M. A., A. Holterman, L. Meuse, A. Gown, H. D. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191-197.
13. King, C. C., B. D. Jamieson, K. Reddy, N. Bali, R. J. Concepcion, and R. Ahmed. 1992. Viral infection of the thymus. J. Virol. 66:3155-3160.
14. Kozarsky, K. F., and J. M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.
15. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
16. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
17. Posselt, A. M., C. F. Barker, J. E. Tomaszewski, J. F. Markmann, M. A. Choti, and A. Naji. 1990. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249:1293-1295.
18. Posselt, A. M., C. F. Barker, A. L. Friedman, and A. Naji. 1992. Prevention of autoimmune diabetes in BB rat by intrathymic islet transplantation at birth. Science 256:1321-1324.
19. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726.
20. Sarzotti, M., D. S. Robbins, and P. M. Hoffman. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271: 1726-1728.
21. Stratford-Perricaudet, L. D., M. Levrero, J. F. Chasse, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:241-256.
22. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
23. Yang, Y., F. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
24. Yang, Y., Z. Xiang, H. C. J. Ertl, and J. M. Wilson. 1995. Upregulation of class I MHC antigens by interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
25. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1994. MHC class-1 restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.